--- title: "Xcelerate Inc. (XCRT.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/XCRT.US.md" symbol: "XCRT.US" name: "Xcelerate Inc." industry: "Health Care Services" --- # Xcelerate Inc. (XCRT.US) | Item | Detail | |------|--------| | Industry | Health Care Services | | Location | US Market | | Website | [www.xcelerate.global](https://www.xcelerate.global) | ## Company Profile Xcelerate Inc. acquires engineering/patents and applies to early-stage medical technology companies. The company engages in the formulation, packaging and marketing of consumer health and beauty, and clinically tested skin care products; development of artificial intelligence and virtual health tech... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-25T04:30:13.000Z **Overall: C (0.49)** **Industry**: Health Care Services | Metric | Value | |--------|-------| | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 0.00% | | | Net Profit YoY | 0.00% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | -5.83 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 6.82M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 2.70M | | **Multi Score**: C #### Profit Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 356.68% | A | | Profit Margin | -49.82% | E | | Gross Margin | 21.76% | D | #### Growth Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 0.00% | C | | Net Profit YoY | 28.13% | B | | Total Assets YoY | 491.00% | A | | Net Assets YoY | -212.60% | E | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -200.72% | D | | OCF YoY | 0.00% | C | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 2.52 | A | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 135.91% | E | ```chart-data:radar { "title": "Longbridge Financial Score - Xcelerate Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "B", "indicators": [ { "name": "ROE", "value": "356.68%", "rating": "A" }, { "name": "Profit Margin", "value": "-49.82%", "rating": "E" }, { "name": "Gross Margin", "value": "21.76%", "rating": "D" } ] }, { "name": "Growth", "grade": "C", "indicators": [ { "name": "Revenue YoY", "value": "0.00%", "rating": "C" }, { "name": "Net Profit YoY", "value": "28.13%", "rating": "B" }, { "name": "Total Assets YoY", "value": "491.00%", "rating": "A" }, { "name": "Net Assets YoY", "value": "-212.60%", "rating": "E" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-200.72%", "rating": "D" }, { "name": "OCF YoY", "value": "0.00%", "rating": "C" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "2.52", "rating": "A" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "135.91%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | TalkSpace (US.TALK) | C | B | A | A | A | A | | 02 | Cigna (US.CI) | B | B | A | D | B | B | | 03 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B | | 04 | Labcorp (US.LH) | B | C | B | C | B | B | | 05 | Quest Diagnostics (US.DGX) | B | B | B | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -6.80 | - | - | - | - | | PB | -5.83 | 65/79 | - | - | - | | PS (TTM) | 2.57 | - | 3.05 | 2.57 | 1.92 | | Dividend Yield | 0.00% | - | - | - | - | ## References - [Company Overview](https://longbridge.com/en/quote/XCRT.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/XCRT.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/XCRT.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.